Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Rotator Cuff Tendinopathy
NCT02867787Phase 2Unknown
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Mar 2014
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in rotator cuff tendinopathy (RCT), sponsored by Centre Hospitalier de Versailles. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
rotator cuff tendinopathy (RCT)
Beyond the preview
Go deeper on NCT02867787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867787.